Despite a favorable safety profile, the widespread use of selective serotonin reuptake inhibitors necessitates awareness of infrequent but significant adverse effects such as cardiac arrhythmias and bleeding complications.
May warrant vigilance for rare SSRI effects like arrhythmias; leaves open need for prospective incidence data.
The selective serotonin reuptake inhibitors have a very favorable safety profile. However, because of the wide use of this drug group, even low-frequency adverse effects become more prevalent. This article reviews 5 of these relatively infrequent adverse medical effects associated with the use of selective serotonin reuptake inhibitors: the syndrome of inappropriate antidiuretic hormone secretion, extrapyramidal effects, bleeding complications, cardiac arrhythmias, and the serotonin syndrome.
No takes yet. Share an insight, caveat, or question.
Richard J. Goldberg (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: